Efficacy and Safety Study of F373280

Clinical trial NCT01831856 · COMPLETED

Trial details

NCT number: NCT01831856
Sponsor: Pierre Fabre Medicament
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2013-04-01
Primary completion: 2017-04-03
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.